Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
OncLive Global Expo
Giants of Cancer Care
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>
<< View all publications

Priority Report

Practical Perspectives on the Diagnosis and Treatment of Hairy Cell Leukemia
Practical Perspectives on the Diagnosis and Treatment of Hairy Cell Leukemia
Therapeutic Advances in Hairy Cell Leukemia   >   Articles
Dr. Traina on Conversations on Extended Adjuvant Therapy With Neratinib in HER2+ Breast Cancer
Dr. Traina on Conversations on Extended Adjuvant Therapy With Neratinib in HER2+ Breast Cancer
Management of Diarrhea in Breast Cancer   >   Videos
Dr. Velez on Managing Neratinib-Associated Diarrhea in HER2+ Breast Cancer
Dr. Velez on Managing Neratinib-Associated Diarrhea in HER2+ Breast Cancer
Management of Diarrhea in Breast Cancer   >   Videos
Advances in the Treatment of Relapsed or Refractory Hairy Cell Leukemia
Advances in the Treatment of Relapsed or Refractory Hairy Cell Leukemia
Therapeutic Advances in Hairy Cell Leukemia   >   Articles
Treatment of Hairy Cell Leukemia: Overview and First-Line Options
Treatment of Hairy Cell Leukemia: Overview and First-Line Options
Therapeutic Advances in Hairy Cell Leukemia   >   Articles
NGS Should Be Administered for All Patients With Advanced or Metastatic Cancer
NGS Should Be Administered for All Patients With Advanced or Metastatic Cancer
Updates in Next-Generation Sequencing   >   Articles
NGS Enables Individualized Treatment Approach in Oncology
NGS Enables Individualized Treatment Approach in Oncology
Updates in Next-Generation Sequencing   >   Articles
Combination Prophylactic Approach Is Best for Neratinib-Associated Diarrhea in HER2+ Breast Cancer
Combination Prophylactic Approach Is Best for Neratinib-Associated Diarrhea in HER2+ Breast Cancer
Management of Diarrhea in Breast Cancer   >   Articles
HRQoL Data Showcase Impact of Prophylactic Regimens With Neratinib in ExteNET and CONTROL Analyses for HER2+ Breast Cancer
HRQoL Data Showcase Impact of Prophylactic Regimens With Neratinib in ExteNET and CONTROL Analyses for HER2+ Breast Cancer
Management of Diarrhea in Breast Cancer   >   Articles
Expert Says Neratinib-Associated Diarrhea Manageable in HER2+ Breast Cancer
Expert Says Neratinib-Associated Diarrhea Manageable in HER2+ Breast Cancer
Management of Diarrhea in Breast Cancer   >   Articles
Next Page >>
Publication Bottom Border
Border Publication
 
x